Skip to content
healthcare.dev

Mirabegron

NDC 67877-890, Mirabegron, for suspension, extended release, from Ascend Laboratories, LLC.

Product NDC
67877-890
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219323
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-890 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON8 mg/mL

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
67877-890-88678770890881 POUCH in 1 CARTON (67877-890-88) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1c9022af-4841-4f3f-9737-1c5eef58e86b
  • NADAC price for package 67877089088

    GET /v1/drugs/nadac/67877089088

Use it

Look up 67877-890 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-890 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-890. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.